May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Frequency, Clinical Findings and Management of Ulcerative Toxic Keratopathy
Author Affiliations & Notes
  • A. Lambiase
    Ophthalmology, University Campus Bio-Medico, Rome, Italy
    GB Bietti Eye Foundation, Rome, Italy
  • M. Sacchetti
    Ophthalmology, University Campus Bio-Medico, Rome, Italy
    GB Bietti Eye Foundation, Rome, Italy
  • M. Coassin
    Ophthalmology, University Campus Bio-Medico, Rome, Italy
  • F. Mantelli
    Ophthalmology, University Campus Bio-Medico, Rome, Italy
  • C. Moretti
    Ophthalmology, University Campus Bio-Medico, Rome, Italy
  • S. Sposato
    Ophthalmology, University Campus Bio-Medico, Rome, Italy
  • S. Bonini
    Ophthalmology, University Campus Bio-Medico, Rome, Italy
    GB Bietti Eye Foundation, Rome, Italy
  • Footnotes
    Commercial Relationships A. Lambiase, None; M. Sacchetti, None; M. Coassin, None; F. Mantelli, None; C. Moretti, None; S. Sposato, None; S. Bonini, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 4325. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Lambiase, M. Sacchetti, M. Coassin, F. Mantelli, C. Moretti, S. Sposato, S. Bonini; Frequency, Clinical Findings and Management of Ulcerative Toxic Keratopathy. Invest. Ophthalmol. Vis. Sci. 2007;48(13):4325.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: toxic effects of topical medications on the ocular surface are documented by several in vivo and in vitro studies. However, few data are available about the incidence and the clinical characteristics of drug-induced toxic keratopathy (TK).This study aims to describe frequency, clinical presentation and management of drug-induced keratopathy.

Methods:: retrospective study on patients with corneal ulcer referred to our tertiary referral center from 2003 to 2005. Diagnosis was based on history, clinical findings, microbiological exams and, occasionally conjunctival biopsy. Toxic keratopathy was diagnosed in presence of negative microbiological exams, absence of identified causes and evidence of corneal healing after discontinuation of all topical treatments except of preservative-free artificial tears. History, clinical findings, visual acuity, symptoms and therapeutic regimen were recorded. The number and the class of topical drugs, the number of instillations per day and the number of days of treatment have been related to the healing time of corneal ulcer by Spearman rho test.

Results:: 226 consecutive corneal ulcers were included: 70 (31%) were infective, 135 (60%) non-infective and 21 (9%) classified as toxic keratopathy (14 male,7 female; mean age 53± 20 years).Ulcerative TK was associated with corneal oedema (43%), superficial neovascolarization (33%), stromal reaction (19%) and deep neovascularization (5%). All patients complained symptoms of ocular surface discomfort. Patients were receiving 1 to 7 different topical drugs, (administration ranging from 5 to 25 times daily) for a mean time of 21.7±12.5 days. All ulcers completely healed after discontinuation of topical treatments (mean healing time: 9.2±5.9 days). Healing time was significantly related to the number of topical drugs used (p=0.029, rho=0.48), to the frequency of drug instillation (p=0.042, rho=0.047) and to the duration of treatment (p=0.049, rho=0.43), but not to any specific drug. At follow-up visits (10.8±11 months), 5 patients showed clear cornea (mean VA=1/1) and 16 patients showed cornea scarring (mean VA=0.4/1±0.3/1).

Conclusions:: Despite the increasing diagnostic and therapeutic tools, TK continues to represent a frequent and misdiagnosed disease. It is mandatory to perform a prompt diagnosis because cornea healing and outcomes are related to treatment duration and frequency of topical drug instillation.

Keywords: drug toxicity/drug effects • cornea: clinical science • keratitis 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×